
16 Dec 2021
Aptose Biosciences Climbs 17% to Reclaim ...
Aptose Biosciences (TSX:APS)(NASDAQ:APTO) recovered 17% after losing 45% this week from results of its drug trial gave investors a ...
Get access to the latest news, guides, stock and crypto updates, and take your financial portfolio to the next level.